BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2881741)

  • 1. Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study.
    Sarin SK; Malhotra V; Sen Gupta S; Karol A; Gaur SK; Anand BS
    Dig Dis Sci; 1987 Apr; 32(4):363-7. PubMed ID: 2881741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue eosinophils in ulcerative colitis.
    Willoughby CP; Piris J; Truelove SC
    Scand J Gastroenterol; 1979; 14(4):395-9. PubMed ID: 482851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential diagnosis of ulcerative and granulomatous colitis by sigmoidoscopy, rectal biopsy and cell counts of rectal mucosa.
    Korelitz BI; Sommers SC
    Am J Gastroenterol; 1974 Jun; 61(6):460-9. PubMed ID: 4835419
    [No Abstract]   [Full Text] [Related]  

  • 4. Lamina propria eosinophils and mast cells in ulcerative colitis: comparison between Asians and Caucasians.
    Benfield GF; Bryan R; Crocker J
    J Clin Pathol; 1990 Jan; 43(1):27-31. PubMed ID: 2312747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophils in the rectal mucosa. A simple method of predicting the outcome of ulcerative proctocolitis?
    Heatley RV; James PD
    Gut; 1979 Sep; 20(9):787-91. PubMed ID: 499919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal-cell counts in ulcerative and granulomatous colitis.
    Sommers SC; Korelitz BI
    Am J Clin Pathol; 1975 Mar; 63(3):359-65. PubMed ID: 234674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses to drug therapy in ulcerative colitis. Evaluation by rectal biopsy and mucosal cell counts.
    Korelitz BI; Sommers SC
    Am J Dig Dis; 1976 Jun; 21(6):441-7. PubMed ID: 8981
    [No Abstract]   [Full Text] [Related]  

  • 8. Responses to drug therapy in ulcerative colitis. Evaluation by rectal biopsy and histopathological changes.
    Korelitz BI; Sommers SC
    Am J Gastroenterol; 1975 Nov; 64(5):365-70. PubMed ID: 2008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cells and eosinophils are involved in activation of ulcerative colitis.
    Stasikowska-Kanicka O; Danilewicz M; Głowacka A; Wągrowska-Danilewicz M
    Adv Med Sci; 2012; 57(2):230-6. PubMed ID: 22968338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy.
    Zezos P; Patsiaoura K; Nakos A; Mpoumponaris A; Vassiliadis T; Giouleme O; Pitiakoudis M; Kouklakis G; Evgenidis N
    Colorectal Dis; 2014 Dec; 16(12):O420-30. PubMed ID: 25040651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis.
    Binder V
    Scand J Gastroenterol; 1970; 5(7):627-32. PubMed ID: 5474435
    [No Abstract]   [Full Text] [Related]  

  • 12. Endoscopic and histological patchiness in treated ulcerative colitis.
    Kim B; Barnett JL; Kleer CG; Appelman HD
    Am J Gastroenterol; 1999 Nov; 94(11):3258-62. PubMed ID: 10566726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum eosinophil cationic protein in active and quiescent ulcerative colitis.
    Pronk-Admiraal CJ; Linskens RK; Van Bodegraven AA; Tuynman HA; Bartels PC
    Clin Chem Lab Med; 2000 Jul; 38(7):619-22. PubMed ID: 11028767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptoms in patients with ulcerative colitis in remission are associated with visceral hypersensitivity and mast cell activity.
    van Hoboken EA; Thijssen AY; Verhaaren R; van der Veek PP; Prins FA; Verspaget HW; Masclee AA
    Scand J Gastroenterol; 2011 Jul; 46(7-8):981-7. PubMed ID: 21623672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentrations of platelet activating factor in rectal mucosa in patients with ulcerative colitis.
    Almer S; Kald B; Franzén L; Ström M; Tagesson C
    Eur J Surg; 1996 May; 162(5):391-6. PubMed ID: 8781921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketotifen therapy for acute ulcerative colitis in children: a pilot study.
    Jones NL; Roifman CM; Griffiths AM; Sherman P
    Dig Dis Sci; 1998 Mar; 43(3):609-15. PubMed ID: 9539658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
    Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic difficulty arising from rectal recovery in ulcerative colitis.
    Levine TS; Tzardi M; Mitchell S; Sowter C; Price AB
    J Clin Pathol; 1996 Apr; 49(4):319-23. PubMed ID: 8655709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue and peripheral eosinophilia as predictors for disease outcome in children with ulcerative colitis.
    Morgenstern S; Brook E; Rinawi F; Shamir R; Assa A
    Dig Liver Dis; 2017 Feb; 49(2):170-174. PubMed ID: 27903418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of disodium cromoglycate on rectal mucosal histamine release, eosinophil exudation and disease activity in active ulcerative colitis.
    Rampton DS; Brown MJ; Causon R; Sahib M
    Clin Allergy; 1982 May; 12(3):243-8. PubMed ID: 6179653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.